WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Charles River Laboratories International, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-10 11:19 am Sale | 2025-12-31 | 13G | CHARLES RIVER LABS INT'L INC CRL | WELLINGTON MANAGEMENT GROUP LLP | 1,749,213 3.600% | -1,441,254 (-45.17%) | Filing |
| 2025-11-12 09:33 am Sale | 2025-09-30 | 13G | CHARLES RIVER LABS INT'L INC CRL | WELLINGTON MANAGEMENT GROUP LLP | 3,190,467 6.500% | -1,094,545 (-25.54%) | Filing |
| 2025-05-12 10:44 am Purchase | 2025-03-31 | 13G | CHARLES RIVER LABS INT'L INC CRL | WELLINGTON MANAGEMENT GROUP LLP | 4,285,012 8.400% | 544,244 (+14.55%) | Filing |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | CHARLES RIVER LABS INT'L INC CRL | WELLINGTON MANAGEMENT GROUP LLP | 3,740,768 7.250% | 2,660,989 (+246.44%) | Filing |